With blockbuster drugs going off patent along with increasing healthcare
costs, pharma sector is now waking up to meet the numerous demands for
packaging of various generic products in India and globally.
The evolving complex regulatory environment in regulated and pharmerging markets is fuelling the demand of high barrier pharma packaging for protecting molecule sensitivity of various drugs to achieve quality, according to experts.
High barrier pharma packaging holds a lot of relevance as sales of big pharma companies like Sanofi, Novartis, Roche, Astrazeneca and Pfizer are threatened in 2014 through patent cliff.
Speaking on the trends in pharma packaging, Johannes Giessler, director, Sales & Marketing, Perlen Packaging recently said, "There is a growth in demand of high barrier specifications, standardized specifications for numerous applications, individual patient packages and counterfeit resistant packaging. Besides this, new legislations are being framed which are increasing costs of products i.e. European falsified medicine directive, ePedigree law etc."
The evolving complex regulatory environment in regulated and pharmerging markets is fuelling the demand of high barrier pharma packaging for protecting molecule sensitivity of various drugs to achieve quality, according to experts.
High barrier pharma packaging holds a lot of relevance as sales of big pharma companies like Sanofi, Novartis, Roche, Astrazeneca and Pfizer are threatened in 2014 through patent cliff.
Speaking on the trends in pharma packaging, Johannes Giessler, director, Sales & Marketing, Perlen Packaging recently said, "There is a growth in demand of high barrier specifications, standardized specifications for numerous applications, individual patient packages and counterfeit resistant packaging. Besides this, new legislations are being framed which are increasing costs of products i.e. European falsified medicine directive, ePedigree law etc."
No comments:
Post a Comment